Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)

Jung Hwa Lee1, Sang Tae Choi, Jin Su Kim

  • 1Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, 4-12 Hwayang-dong Gwangjin-gu, Seoul 143-729, Korea.

Rheumatology International
|November 28, 2012
PubMed

Insights

Polymyalgia rheumatica (PMR) in Korean patients shows similar characteristics to Western populations but with a lower remission rate. Relapse risk factors include high initial C-reactive protein and hydroxychloroquine use, suggesting a need for tailored management strategies.

Area of Science:

  • Rheumatology
  • Epidemiology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a common inflammatory condition in the elderly, with varying prevalence across different populations.
  • Epidemiological data on PMR in Korea is limited, necessitating further investigation into its characteristics within this demographic.

Purpose of the Study:

  • To retrospectively evaluate the clinical data of Korean patients diagnosed with PMR.
  • To analyze initial laboratory findings, symptoms, treatment responses, and prognostic factors for relapse within one year.

Main Methods:

  • Retrospective analysis of clinical data from 78 PMR patients treated at five tertiary hospitals.
  • Evaluation of initial laboratory data, symptoms, therapeutic responses, and relapse rates at one year.

Main Results:

  • Sixty percent of patients experienced shoulder and hip girdle pain, with elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
  • The 1-year relapse rate was 38.4%, with overall relapse at 46.1%, occurring predominantly within the first year.
  • Independent risk factors for relapse included initial CRP ≥ 2.5 mg/dl and hydroxychloroquine use; female gender and higher cumulative steroid dose were associated with relapse.

Conclusions:

  • Korean PMR patients exhibit similar baseline characteristics and relapse rates to Western cohorts but notably lack associated giant cell arteritis.
  • Lower remission rates, delayed therapeutic response, and later relapse occurrence were observed in this Korean cohort.
  • More aggressive and individualized management strategies may be required for Korean patients with PMR based on their clinical status and identified risk factors.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...